Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZEPATIER safely and effectively. See full prescribing information for ZEPATIER. ZEPATIER® (elbasvir and grazoprevir) tablets, for oral use Initial U.S. Approval: 2016
Medication labelWhy this: Advisory · dailymed-prescription
ZEPATIER® is indicated for the treatment of chronic hepatitis C virus (HCV) genotype 1 or 4 infection in adult and pediatric patients 12 years of age and older or weighing at least 30 kg. ZEPATIER is indicated for use with ribavirin in certain patient populations [see Dosage and Administration (2.2)].
- generic_name
- elbasvir and grazoprevir
- product_names
- elbasvir and grazoprevir
- ndc
- 0006-3074, 0006-3074-01, 0006-3074-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en